Transitions Optical in Canada has pledged their support of Gabrielle Ouellet’s GO Challenge benefitting the Fondation des maladies de l’œil (FMO) (Eye Disease Foundation). Former international model Ouellet, known as “the girl with the cat eyes,” has launched her challenge to raise money for vision health research.
Ouellet was born with a rare genetic condition called Cat Eye Syndrome, and as a result has been interested in helping to fund research into eye diseases for a number of years. It wasn’t until she ran her first half marathon in 2016 that she saw the opportunity to combine her newfound passion with her philanthropic efforts. As a result, Ouellet launched the GO Challenge where she will run 126.6 kilometers across three marathons in Montréal, Québec and Toronto in less than a month to benefit the FMO and eye research.
“Gabrielle is a driven, vivacious young woman, and her amazing life story demonstrates this admirably,” said Isabelle Tremblay, director of sales and marketing, Transitions Optical Canada. “She’s an inspiration not only for people with visual impairments but for anyone who, like Transitions, strives for societal values of renewal, excellence and self-improvement. As soon as Transitions heard about her daring GO Challenge we wanted to tip our hats to her courageous spirit and support this determined young woman.”
EssilorLuxottica yesterday released the three-year clinical trial results of the Essilor Stellest lens, for the first time at the International Myopia Conference (IMC) 2022 in Rotterdam, Netherlands.
The results show that the Essilor Stellest lenses continue to exhibit strong efficacy in slowing myopia progression and axial elongation in the third year of the clinical trial.
EssilorLuxottica’s partnership with IMC as a diamond sponsor this year continues to demonstrate the Group’s strong commitment to sharing insights and expertise on myopia control globally and providing innovative solutions for children to help slow down their myopia progression.
Satellite Session Highlights. EssilorLuxottica’s satellite session was facilitated by Dr. Mark A. Bullimore, MCOptom, PhD, FAAO – University of Houston, College of Optometry Professor, and Olga Prenat, Head, Medical Marketing, Professional Relations and Vision Care Education, EssilorLuxottica.
The session titled ‘Essilor Stellest lens – New benefits of myopia control spectacle lenses’ saw presentations from EssilorLuxottica’s research and development experts, Dr. Damien Paillé and Dr. Björn Drobe.
The clinical trial was conducted at the Eye Hospital of Wenzhou Medical University in Wenzhou, China, where 151 children from the first two years of the study were switched to spectacle lenses with highly aspherical lenslets (HAL) while a new set of 56 children were recruited and wore single vision lenses.
Key highlights from the clinical trial include:
● Essilor Stellest lenses saved more than one diopter of myopia on average over three years, demonstrating conclusive evidence that they remain effective in slowing down myopia progression in children in the third year.
● The results confirmed the significant positive impact of wearing time on myopia control efficacy. Children who wore Essilor Stellest lenses full time saw a marked increase in myopia control efficacy.
● Aside from being effective in younger children, the results confirm that the Essilor Stellest lenses are also effective in slowing myopia progression and axial elongation in older children.
Norbert Gorny, coChief Operating Officer at EssilorLuxottica, said, “ We are extremely encouraged to have such conclusive data showing that Essilor Stellest lenses continue to slow down myopia progression in children after three years. With the growing prevalence of myopia and associated risk of ocular conditions, we are proud to be at the forefront of myopia management with our lenses to move the needle in the fight against myopia. The lens is now available in more than 20 countries, and we will continue to expand our footprint in the future and help advance knowledge and education of myopia management to ensure that everyone understands the importance and benefits of managing myopia early and proactively in children.”
EssilorLuxottica is also one of three GOLD SPONSORs of THE Myopia Meeting Canada, which makes its debut in Toronto on November 6th.
Canada is marking September as the first annual Inherited Retinal Disease Awareness Month, resulting from advocacy efforts by Fighting Blindness Canada (FBC) to Health Canada to recognize individuals living with genetic conditions that lead to vision loss. Inherited retinal diseases (IRDs) are caused by a specific genetic mutation or mutations that impact how retinal cells work and survive which impact vision.
“Researchers have found more than 300 genes that cause IRDs, which cause damage to the retina in the back of the eye and ultimately lead to vision loss, either at birth or later in life,” explains Doug Earle, President and CEO of Fighting Blindness Canada (FBC). “However, research is constantly changing the outcomes for people living with these conditions. There are new treatments that can slow down, stop or even reverse the progression of disease, giving people immense hope of a future without blindness.”
FBC commissioned Deliotte Access Economics to deliver “IRD Counts” in 2020 that identified the annual socio-economic impact of IRDs in Canada as $1.6 billion. Over 80% of the impact is borne by families living with IRDs.
Although there are differences between IRDs, they all result in vision loss due to retinal damage in the back of the eye. Among the more than 20 types of IRDs include retinitis pigmentosa, Stargardt disease, Usher syndrome, and Leber congenital amaurosis. Genetic testing may help pinpoint which mutation causes an IRD and can provide important information as more clinical trials and treatments are developed.
As part of IRD Awareness Month, FBC is inviting Canadians to participate in the following:
Join FBC’s Facebook Live on IRDs with Dr. Rob Koenekoop, Paediatric Ophthalmologist at Montreal Children’s Hospital on Friday, September 23 at 12:30 pm EDT
Today, Dragon, a proprietary brand of Marchon Eyewear Inc., announces a new partnership with social enterprise, Plastic Bank. Dragon, a leader in the performance eyewear space with deep roots in the action sports world has implemented a plastic offset impact program, where each pair of Dragon optical frames, sunglasses, and snow goggles sold will prevent the equivalent of 10 plastic bottles from entering the ocean in collaboration with Plastic Bank.
The partnership will help stop ocean plastic and improve the lives of collection community members in vulnerable coastal areas. With this collaboration, the two companies are creating environmental, social, and economic impact. By choosing Dragon eyewear, customers are contributing to Dragon’s annual commitment of stopping over 85,600 kg of ocean-bound plastic from entering the ocean – that’s the equivalent of over 4,280,000 million single-use plastic bottles.
“We are very proud to announce our partnership with Plastic Bank, and Dragon is a natural fit,” said Thomas Burkhardt, President of Marchon Eyewear, Inc. “By collaborating with Plastic Bank, we are solidifying our commitment to social responsibility and sustainable initiatives, while also tying it back to the brand’s heritage in surf.”
“Around 11 million tons of plastic waste is flowing each year into the ocean. We keep talking about climate change when what we need to focus on is business change like the one brought about by Marchon for Dragon. Thank you for empowering your consumers with the choice to be part of the solution,” said David Katz, Founder of Plastic Bank.
To bring patients extra style this summer, Transitions® XTRActive® new generations lenses come in five stunning Style Mirror colours. Available in gold, silver, copper, blue green and blue violet, wearers can create all their own by pairing any colour lens with their favorite frames. Plus, these light intelligent lenses adapt seamlessly to any lighting environment providing the icon look patients want with the all-day protection they need. So, your patients have the choice to select the iconic colors as Grey, Brown and Graphite Green and add some style with one of the 5 mirrors.
Compared to the old Transitions XTRActive lenses, this new generation is darker overall[vi], darker in hot temperatures and in the car, and up to 35% faster to fade back[vii]. These advances are possible thanks to the new nano-composite matrix technology combined with new, extra powerful broad spectrum dyes which activate in both the UV and visible light spectrum.
“People are experiencing increased symptoms of eye strain and discomfort whether inside from screens or outdoors, and Transitions XTRActive lenses were designed with this issue in mind. In fact, three out of ten eyeglass wearers are very light sensitiveiv” said Brian O’Neil, Ph.D., global vice president, Innovation, Technology & Operations, Transitions Optical. “Wearers of Transitions Optical technology want flexibility between indoors, outdoors and driving to be better protected at all times. The new generation of Transitions XTRActive provides light protection regardless of the situation.”
In addition to this new generation, Transitions Optical began the rolling launch of Transitions® XTRActive® Polarized™ in Canada in January 2021. Both products provide extra protection for eyeglass wearers who are frequently in intense light situations or who are very light sensitive. Transitions XTRActive Polarized is an extension of the Transitions XTRActive range bringing the additional benefits of polarization to the extra dark photochromic category, while Transitions XTRActive new generation lenses offer the best extra darkness[viii]. Transitions XTRActive Polarized lenses are designed for patients who want extra protection in high-glare situations. The unique polarization technology reduces glare outdoors, providing sharper vision, a larger field of view and bright, vivid colours.
Transitions XTRActive new generation and Transitions XTRActive Polarized lenses are available now. Please contact your local laboratory that provides you the Transitions XTRActive portfolio to know more about their product availability.
[i] In the clear to dark photochromic category. Tests across polycarbonate and 1.5 grey lenses at 35°C achieving <18%T using Transitions Optical’s standard testing method.
[ii] Clear to dark photochromic category. Polycarbonate and 1.5 grey lenses tested at 23°C behind the windshield achieving between 18%T and 43%T.
[iii] Clear to dark photochromic category. Tested on grey lenses across materials at 23°C outdoors achieving >8%T (Category 3 Darkness Levels) using Transitions Optical’s standard testing method.
[iv] Protection from harmful blue light (380nm-460nm) across the following light situations: indoors at 23°C, behind the windshield and outdoors at 23°C, among polycarbonate and 1.5 grey lenses in the clear to dark photochromic category.
[v] From harmful blue light (380nm-460nm) at 23°C among polycarbonate and 1.5 grey lenses in the clear to dark photochromic category.
iv Transitions Optical, Quality of Vision and Vision Experience Test in Controlled Lab Situations (Lab Wearer Testing), U.S., Eurosyn, Q4 2019, N=135.
[vi] Compared to the previous generation, across materials tested on grey lenses at 23°C and 35°C.
[vii] Compared to the previous generation, across materials tested on grey lenses fading back to 70% transmission at 23°C.
[viii] In hot temperatures and in the car in the clear to dark photochromic category. Tests across polycarbonate and 1.5 grey lenses at 23°C and 35°C using Transitions Optical’s standard testing method.
The American Academy of Optometry (AAO) was recognized as a Cochrane Eyes and Vision (CEV) Center for Evidence-based Vision Care during Academy 2024 Indianapolis, November 6-9, 2024.
K-774’s retro-inspired look features patterned base acetate and custom lamination on the temple, creating a striking look where colours blend seamlessly.
The American Academy of Optometry (AAO) was recognized as a Cochrane Eyes and Vision (CEV) Center for Evidence-based Vision Care during Academy 2024 Indianapolis, November 6-9, 2024.
K-774’s retro-inspired look features patterned base acetate and custom lamination on the temple, creating a striking look where colours blend seamlessly.
The American Academy of Optometry (AAO) was recognized as a Cochrane Eyes and Vision (CEV) Center for Evidence-based Vision Care during Academy 2024 Indianapolis, November 6-9, 2024.
K-774’s retro-inspired look features patterned base acetate and custom lamination on the temple, creating a striking look where colours blend seamlessly.
The American Academy of Optometry (AAO) was recognized as a Cochrane Eyes and Vision (CEV) Center for Evidence-based Vision Care during Academy 2024 Indianapolis, November 6-9, 2024.
K-774’s retro-inspired look features patterned base acetate and custom lamination on the temple, creating a striking look where colours blend seamlessly.
